Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin

European Journal of Pediatrics

Volumn 167, Issue 10, 2008, Pages 1119-1123

  Miura, Masaru ^a,b   Kohno, Kazuki ^a   Ohki, Hirotaka ^a   Yoshiba, Shigeki ^a   Sugaya, Akinori ^a   Satoh, Masaaki ^a  

^a TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^b NONE   (Japan)

Author keywords

Cytokine; Kawasaki disease; Steroid pulse

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VENOGLOBULIN IH;

AIR EMBOLISM; ARTICLE; BRADYCARDIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG PULSE THERAPY; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHERMIA; LEUKOCYTE COUNT; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ACUTE DISEASE; ADULT; CHEMOKINE CCL2; CYTOKINES; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-6; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PULSE THERAPY, DRUG; RECEPTORS, INTERLEUKIN-2; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 50249127164     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0642-5     Document Type: Article

References (16)

1. JC Burns WH Mason SB Hauger H Janai JF Bastian JD Wohrley I Balfour CA Shen ED Michel ST Shulman ME Melish 2005 Infliximab treatment for refractory Kawasaki syndrome J Pediatr 146 662 667
2. GWK Gong BW McCrindle JC Ching RSM Yeung 2006 Arthritis presenting during the acute phase of Kawasaki disease J Pediatr 148 800 805
3. K Hashino M Ishii M Iemura T Akagi H Kato 2001 Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy Pediatr Int 43 211 217
4. JS Hui-Yuen TT Duong RSM Yeung 2006 TNF-α is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease J Immunol 176 6294 6310
5. CY Lin CC Lin B Hwang BN Chiang 1993 Cytokines predict coronary aneurysm formation in Kawasaki disease patients Eur J Pediatr 152 309 312
6. PA Mackowiak 1998 Concepts of fever Arch Intern Med 158 1870 1881
7. M Miura H Ohki S Yoshiba H Ueda A Sugaya M Satoh 2005 Adverse effects of mthylprednisolone pulse therapy in refractory Kawasaki disease Arch Dis Child 90 1096 1099
8. JW Newburger LA Sleeper BW McCrindle LL Minich W Gersony VL Vetter AM Atz JS Li M Takahashi AL Baker SD Colan PD Mitchell GL Klein RP Sundel Pediatric Heart Network Investigators 2007 Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease N Engl J Med 356 663 675
9. JW Newburger M Takahashi MA Gerber MH Gewitz LY Tani JC Burns ST Shlman AF Bolger P Ferrieri RS Baltimore WR Wilson LM Baddour ME Levison TJ Pallasch DA Falace KA Taubert 2004 Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2747 2771
10. Y Okada M Shinohara T Kobayashi Y Inoue T Tomomasa T Kobayashi A Morikawa Gunma Kawasaki Disease Study Group 2003 Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children J Pediatr 143 363 367
11. PJ Pentikäinen 1984 Pharmacological aspects of corticosteroid pulse therapy Scand J Rheumatol 54 suppl 6 9
12. M Teari T Jibiki A Harada Y Terashima K Yasukawa S Tateno H Hamada S Oana H Niimi K Matsushima 1999 Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment J Leukoc Biol 65 566 572
13. M Wong ED Silverman EN Fish 1997 Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease J Rheumatol 24 1179 1185
14. PK Wong C Cuello JV Bertouch PJ Roberts-Thomson MJ Aheren MD Smith PP Youssef 2001 Effects of pulse methylprednisolone on macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha in rheumatoid synovium J Rheumatol 28 2634 2636
15. DA Wright JW Newburger A Baker RP Sundel 1996 Treatment of immune globulin-resistant Kawasaki disease pulsed dose of corticosteroids J Pediatr 128 146 149
16. PP Youssef DR Haynes S Triantafillou A Parker JR Gamble PJ Roberts-Thomson MJ Ahern MD Smith 1997 Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis Arthritis Rheum 40 1400 1408